subscribe
 

Men with incurable prostate cancer living for twice as long as decade ago

Patients with advanced prostate cancer treated with the latest therapies are living on average for more than twice as long as a decade ago, a striking new analysis reveals.



Cheaper anti-cancer drug as effective as expensive drug in treating most common cause of blindness in older adults

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.



"Intelligent knife" tells surgeon which tissue is cancerous

Scientists have developed an "intelligent knife" that can tell surgeons immediately whether the tissue they are cutting is cancerous or not.



‘Homing’ radioactive injection shows benefit in phase III prostate cancer trial

An ingenious new treatment for advanced prostate cancer, which homes in on tumours to deliver a high-energy burst of radiation to cancer cells, has shown significant benefits to patients in a large-scale clinical trial.



Measles virus improves radiotherapy treatment

An innovative new combination treatment that uses the measles virus to target cancer cells could significantly improve treatment for bowel and head & neck cancer, new research suggests.



Molecular discovery puts cancer treatment in a new perspective

Researchers from the University of Copenhagen and the National Institutes of Health have obtained ground-breaking new knowledge about proteases - important enzymes which, among other things, play a role in the development of cancer cells.



Patent for molecule that helps fight cancer

A key activation molecule which enables the body’s own immune system to fight cancer, developed by the University of Southampton, has been issued a US patent.



Sniffing out bladder cancer – new diagnostic test

Researchers from the University of the West of England, the University of Liverpool and the Bristol Urological Institute have developed a device using sensor technology that may help diagnose patients with early signs of bladder cancer.



Scientists make major advances important for cancer research

Scientists at the University of East Anglia have made a major advancement in understanding tissue development that has important implications for cancer.



Curie-Cancer and Sanofi cooperate in research on ovarian cancer

Sanofi and the Curie Institute, through its Curie-Cancer partnership under the Institut Carnot label, have announced the establishment of a three-year research collaboration to identify new therapeutic targets for the development of treatments for ovarian cancer.



‘Next generation’ cancer drug shows promise in early trial

A new potential cancer drug has shown promising results in an early stage clinical trial. The drug, called AUY922, could help lead to a new way to treat a wide range of cancers including breast and lung cancer.



New 2-3 day patient-applied product for sun-damaged skin that can lead to skin cancer

A new treatment for sun-damaged skin that can lead to skin cancer is launched by LEO Pharma



Curie-Cancer and Biolog-id sign partnership agreement

Within the partnership, Curie-Cancer and Biolog-id will develop a pilot system of RFID tags suitable for use in tracking cancer chemotherapy preparations



Arthritis Research UK - Promoting effective and efficient reporting

In a world increasingly focused on accountability, over 30 leading research funding organisations including Arthritis Research UK have joined forces to use a new research outcomes reporting system called Researchfish.



Study confirms Everolimus can overcome Trastuzumab resistance in IN HER-2 positive early breast cancer

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.



Pages

Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe